Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

275 Views

Poster Session: COVID-19: Treatment

1133 - Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Takao Sanaki, PhD

Associate Senior Scientist
SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan

Co-Author(s)

KB

Keiko Baba, MA

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
AY

Atsuko Yamamoto, MA

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
HN

Haruaki Nobori, MA

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
SU

Shota Uehara, Ph.D.

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
YK

Yoko Kajiwara, Ph.D.

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
RY

Ryu Yoshida, Ph.D.

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
HS

Hiroki Sakaguchi, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
TH

Takahiro Hasegawa, DrPH

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
AH

Akifumi Hatanaka, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
GI

Genki Ichihashi, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
YT

Yosuke Takeda, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
TS

Takao Shishido, Ph.D.

SHIONOGI & CO., LTD.
Toyonaka-shi, Osaka, Japan
TU

Takeki Uehara, Ph.D.

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan